# A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study

> **NCT02013089** · NA · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 50 (estimated)

## Conditions studied

- Gastrointestinal Cancers

## Interventions

- **DRUG:** Erlotinib or Gefitinib
- **DRUG:** Everolimus
- **DRUG:** Imatinib
- **DRUG:** Sorafenib or Sunitinib
- **DRUG:** Vandetanib

## Key facts

- **NCT ID:** NCT02013089
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2017-05
- **Final completion:** 2017-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02013089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02013089, "A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02013089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*